$11.15
0.030.27%
At close: Jun 8, 5:00 PM EST
$11.10
-0.05-0.45%
After Hours: 4:45 PM EST
Corvus Pharmaceuticals Inc Earnings Estimates
CRVSNASDAQ
Corvus Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:CRVS
Corvus Pharmaceuticals (CRVS) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $-0.17 and quarterly revenue of N/A.
In the most recent quarter (Q1), Corvus Pharmaceuticals reported EPS of $-0.15, meeting estimates of $-0.15. Revenue came in at $0.00, missing the estimate of $620.00K by 1.00%.
Over the last 4 quarters, Corvus Pharmaceuticals has averaged an EPS surprise of 0.11% and a revenue surprise of 1.00%.
Earnings Date
Aug 6
EPS Estimate
$-0.170
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Corvus Pharmaceuticals Earnings History
Analyze the earnings history of Corvus Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Corvus Pharmaceuticals (CRVS) Earnings Per Share
The chart below shows Corvus Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Corvus Pharmaceuticals (CRVS) Revenue
The chart below shows Corvus Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Corvus Pharmaceuticals (NASDAQ:CRVS) reporting earnings?
Corvus Pharmaceuticals (CRVS) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for Corvus Pharmaceuticals (NASDAQ:CRVS)?
The Actual EPS was $-0.15, which hit the estimate of $-0.15.
What were Corvus Pharmaceuticals’s (NASDAQ:CRVS) revenues?
The Actual Revenue was $0.00, which missed the estimate of $620.00K.
